Popular Articles
Natural Remedies

Divisions Over Future Medicare Spending Surface In House
"A week-old agreement among House Democrats to smooth out disparities in the way Medicare reimburses rural and urban health providers is in danger of crumbling, as disputes erupted Friday over what actually was agreed to," The Wall Street Journal reports. "Some lawmakers from states with high health-care costs are also pressing House Democratic leaders for changes to the deal to ensure that their doctors and hospitals don"t see too big of a bite. ò€¦ Lawmakers from populous areas are questioning whether the deal on geographic disparities should be altered to allow more time for Medicare changes to take effect, since there is no longer the urgency of putting those changes into effect before the public option is rolled out. Another issue is for how long a period of time after changes go into effect urban hospitals should be "held harmless," meaning they won"t see their Medicare reimbursements cut" (Vaughan, 8/2).
generic viagra online
Mass. Panel Recommends Scrapping Doctors, Hospitals Payment System
The Boston Globe: "A state commission recommended yesterday that Massachusetts dramatically change how doctors and hospitals are paid, essentially putting providers on a budget as a way to control exploding healthcare costs and improve the quality of care. The 10-member commission, which includes key legislators and members of Governor Deval Patrick"s administration, voted unanimously to largely scrap the current system, in which insurers typically pay doctors and hospitals a negotiated fee for each individual procedure or visit. That arrangement is widely seen as leading to unneeded tests and procedures. Instead, the group wants private insurers and the state and federal Medicaid program to pay providers a set payment for each patient that covers all that person"s care for an entire year and to make the radical shift within five years" (Kowalczyk, 7/17).
News of the day
IOPHARM Presents Positive Indibulin Translational And Dose Scheduling Data At ASCO
ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that it presented positive data from both a Phase Ib clinical trial and preclinical dosing studies of orally administered indibulin (ZybulinTM or ZIO-301), the Company"s novel tubulin binding agent, at the 45th Annual American Society of Clinical Oncology (ASCO) meeting held in Orlando, FL, May 29th to June 2nd.
Health Insurance

Scientists Examine HIV's Effect On Immune System

A study by researchers from Duke University and the University of North Carolina-Chapel Hill and published in PLoS Medicine has found that upon infection "three lines of attack by the immune system are quickly neutralized by HIV," findings they hope "will provide a better understanding of how to develop a vaccine to protect against the virus," the Raleigh News & Observer reports. The study, lead by Duke"s Barton Haynes, showed that HIV, "once considered a slow if stealthy invader, actually works incredibly fast at disarming key immune fighters in the body." Haynes said scientists still have a difficult task in developing a vaccine, adding, "It would have to be different than any other vaccine made" (Avery, 7/7). This information was reprinted from dailyreports.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily U.S. HIV/AIDS Report, search the archives and sign up for email delivery at dailyreports.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):